Trials / Completed
CompletedNCT02528838
An Observational Study to Assess Safety and Outcome of the Various Medication Usage Patterns in Clinical Routine Practice in Patients Receiving Lenalidomide.
A Non-interventional Observational Post Authorization Study to Assess Safety and Outcome of the Various Medication Usage Patterns in Clinical Routine Practice in Patients Receiving Lenalidomide (REVIEW)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 238 (actual)
- Sponsor
- Celgene · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is designed as a prospective, non-interventional, observational single arm study. Hundred-fifty patients over 18 with stable disease or at least partial response while on treatment with lenalidomide will be recruited from approximately 20 haematology/oncology sites in the Netherlands. Recruitment will continue until 150 patients have started the study. When this target is reached, all patients on lenalidomide will continue to be followed until the last patient has been followed for 36 months.
Conditions
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2016-06-30
- Completion
- 2018-01-15
- First posted
- 2015-08-19
- Last updated
- 2020-05-27
Source: ClinicalTrials.gov record NCT02528838. Inclusion in this directory is not an endorsement.